1. Curcumin and resveratrol inhibit chemoresistance in cisplatin-resistant epithelial ovarian cancer cells via targeting P13K pathway
    Yalikun Muhanmode et al, 2022, Human & Experimental Toxicology CrossRef
  2. A potential therapeutic target in traditional Chinese medicine for ulcerative colitis: Macrophage polarization
    Zhihua Yang et al, 2022, Frontiers in Pharmacology CrossRef
  3. Sirtuin family in autoimmune diseases
    Zhengjie Tao et al, 2023, Frontiers in Immunology CrossRef
  4. Fenofibrate as an Adjunct Therapy for Ulcerative Colitis: Targeting Inflammation via SIRT1, NLRP3, and AMPK Pathways: A Randomized Controlled Pilot Study
    Sumaiah J Alarfaj et al, 2024, Drug Design, Development and Therapy CrossRef
  5. Effects of Dietary Grape Seed Meal Bioactive Compounds on the Colonic Microbiota of Weaned Piglets With Dextran Sodium Sulfate-Induced Colitis Used as an Inflammatory Model
    Iulian A. Grosu et al, 2020, Frontiers in Veterinary Science CrossRef
  6. Therapeutic Effects of Resveratrol in Inflammatory Bowel Diseases: Shedding Light on the Role of Cellular and Molecular Pathways
    Marjan Talebi et al, 2022, Revista Brasileira de Farmacognosia CrossRef
  7. Cannabis sativa alleviates experimentally acetic acid- induced ulcerative colitis in rats: targeting CB1/SIRT/MAPK signaling pathways
    Rania Elgohary et al, 2024, Immunopharmacology and Immunotoxicology CrossRef
  8. Chapter 16: Vitagenes in gut health and immunity
    Peter F. Surai, 2020, Vitagenes in avian biology and poultry health CrossRef
  9. Resveratrol alleviates intestinal mucosal barrier dysfunction in dextran sulfate sodium-induced colitis mice by enhancing autophagy
    Hang-Hai Pan et al, 2020, World Journal of Gastroenterology CrossRef
  10. Resveratrol for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis
    Yuting Gu et al, 2024, Frontiers in Pharmacology CrossRef
  11. A new therapy against ulcerative colitis via the intestine and brain using the Si-based agent
    Yoshihisa Koyama et al, 2022, Scientific Reports CrossRef
  12. Berberine Administration in Treatment of Colitis: A Review
    Milad Ashrafizadeh et al, 2020, Current Drug Targets CrossRef
  13. Curcumin alleviated dextran sulfate sodium-induced colitis by recovering memory Th/Tfh subset balance
    Lin-Xin Zheng et al, 2023, World Journal of Gastroenterology CrossRef
  14. Dietary polyphenols in the treatment of inflammatory bowel diseases
    Açelya Gül Koyuncu et al, 2022, Journal of Surgery and Medicine CrossRef
  15. Efficacy of oral consumption of curcumin/ for symptom improvement in inflammatory bowel disease: A systematic review of animal models and a meta-analysis of randomized clinical trials
    MARLA DE CERQUEIRA ALVES et al, 2022, BIOCELL CrossRef
  16. Natural compounds target programmed cell death (PCD) signaling mechanism to treat ulcerative colitis: a review
    Bo Chen et al, 2024, Frontiers in Pharmacology CrossRef
  17. Alternative Therapy in the Prevention of Experimental and Clinical Inflammatory Bowel Disease. Impact of Regular Physical Activity, Intestinal Alkaline Phosphatase and Herbal Products
    Jan Bilski et al, 2020, Current Pharmaceutical Design CrossRef
  18. Harnessing nature’s pharmacy: investigating natural compounds as novel therapeutics for ulcerative colitis
    You Huang et al, 2024, Frontiers in Pharmacology CrossRef
  19. The role of autophagy in maintaining intestinal mucosal barrier
    Yanping Wu et al, 2019, Journal of Cellular Physiology CrossRef